MLXIPL and Hyperglycemia: When type 2 diabetes (T2D) occurs in obese individuals, hyperglycemia can also contributes to fatty liver by activating carbohydrate responsive element-binding protein (ChREBP), a transcription factor that enhances the expression of several glycolytic and lipogenic enzymes [9,12].